Daily Discoveries
With a Ph.D. in molecular biology and an MBA from Indiana University and an undergraduate background at the University of Notre Dame, Dr. Christina Kiley was a natural fit to join Eli Lilly and Company, which has a large presence in Indianapolis. Since 2009, Dr. Kiley has held a variety of roles at the biopharmaceutical company, blending both business and research. Today she leads drug development teams in Lilly’s immunology and neurodegeneration portfolios. In 2017, Dr. Kiley was designated a Trailblazer in Lilly’s effort to transform research and advance drugs with novel mechanisms quickly to proof of concept.